001025208 001__ 1025208
001025208 005__ 20250203103227.0
001025208 0247_ $$2doi$$a10.1093/neuonc/noad137.075
001025208 0247_ $$2ISSN$$a1522-8517
001025208 0247_ $$2ISSN$$a1523-5866
001025208 0247_ $$2WOS$$aWOS:001300535600076
001025208 037__ $$aFZJ-2024-02776
001025208 082__ $$a610
001025208 1001_ $$0P:(DE-Juel1)173675$$aKocher, M.$$b0$$eCorresponding author$$ufzj
001025208 1112_ $$a18th Meeting of the European Association of Neuro-Oncology$$cRotterdam$$d2023-09-21 - 2023-09-24$$wNetherlands
001025208 245__ $$aP01.01.A THE IMPACT OF BRAIN LESIONS ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH WHO CNS GRADE 3 OR 4 GLIOMA: A LESION-FUNCTION AND RESTING-STATE FMRI ANALYSIS
001025208 260__ $$c2023
001025208 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1714564290_354
001025208 3367_ $$033$$2EndNote$$aConference Paper
001025208 3367_ $$2BibTeX$$aINPROCEEDINGS
001025208 3367_ $$2DRIVER$$aconferenceObject
001025208 3367_ $$2DataCite$$aOutput Types/Conference Abstract
001025208 3367_ $$2ORCID$$aOTHER
001025208 520__ $$aBACKGROUNDIn glioma patients, tumor development and multimodality therapy are associated with changes in health-related quality of life (HRQoL). It is largely unknown how different types and locations of tumor- and treatment-related brain lesions, as well as their relationship to white matter tracts and functional brain networks, affect HRQoL.MATERIAL AND METHODSIn 121 patients with pretreated gliomas of WHO CNS grades 3 or 4, structural MRI, O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET, resting-state functional MRI (rs-fMRI) and self-reported HRQoL questionnaires (EORTC QLQ-C30/BN20) were obtained. Resection cavities, T1-enhancing lesions, T2/FLAIR hyperintensities, and lesions with pathologically increased FET uptake were delineated. Effects of tumor lateralization, involvement of white matter tracts or resting-state network nodes by different types of lesions and within-network rs-fMRI connectivity were analyzed in terms of their interaction with HRQoL scores.RESULTSRight hemisphere gliomas were associated with significantly less favorable outcomes in physical, role, emotional and social functioning, compared with left-sided tumors. Most functional HRQoL scores correlated significantly with right-sided white-matter tracts involvement by T2/FLAIR hyperintensities and with loss of within-network functional connectivity of right-sided nodes. Tumors of the left hemisphere caused significantly more communication deficits.CONCLUSIONIn pretreated high-grade gliomas, right hemisphere lesions are associated with reduced HRQoL scores in most functional domains except communication ability, compared to tumors of the left hemisphere. These relationships are mainly observed for T2/FLAIR lesions involving structural and functional networks in the right hemisphere. The data suggest that sparing the right hemisphere from treatment-related tissue damage may improve HRQoL in glioma patients.
001025208 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001025208 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001025208 7001_ $$0P:(DE-Juel1)132315$$aHeinzel, A.$$b1
001025208 7001_ $$0P:(DE-HGF)0$$aMottaghy, F. M.$$b2
001025208 7001_ $$0P:(DE-Juel1)141877$$aFilss, C.$$b3$$ufzj
001025208 7001_ $$0P:(DE-Juel1)131627$$aStoffels, G.$$b4$$ufzj
001025208 7001_ $$0P:(DE-Juel1)145110$$aLohmann, P.$$b5$$ufzj
001025208 7001_ $$0P:(DE-Juel1)184842$$aFriedrich, M.$$b6$$ufzj
001025208 7001_ $$0P:(DE-Juel1)131794$$aShah, N. J.$$b7$$ufzj
001025208 7001_ $$0P:(DE-Juel1)131675$$aCaspers, S.$$b8$$ufzj
001025208 7001_ $$0P:(DE-HGF)0$$aWeiss Lucas, C.$$b9
001025208 7001_ $$0P:(DE-HGF)0$$aRuge, M. I.$$b10
001025208 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, N.$$b11$$ufzj
001025208 7001_ $$0P:(DE-Juel1)131720$$aFink, G. R.$$b12$$ufzj
001025208 7001_ $$0P:(DE-Juel1)131777$$aLangen, K.$$b13$$ufzj
001025208 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noad137.075$$gVol. 25, no. Supplement_2, p. ii25 - ii25$$x1523-5866$$y2023
001025208 909CO $$ooai:juser.fz-juelich.de:1025208$$pVDB
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)173675$$aForschungszentrum Jülich$$b0$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)141877$$aForschungszentrum Jülich$$b3$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131627$$aForschungszentrum Jülich$$b4$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b5$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)184842$$aForschungszentrum Jülich$$b6$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich$$b7$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131675$$aForschungszentrum Jülich$$b8$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b11$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b12$$kFZJ
001025208 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b13$$kFZJ
001025208 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001025208 9141_ $$y2024
001025208 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-24$$wger
001025208 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2022$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-24
001025208 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bNEURO-ONCOLOGY : 2022$$d2023-10-24
001025208 9201_ $$0I:(DE-Juel1)INM-1-20090406$$kINM-1$$lStrukturelle und funktionelle Organisation des Gehirns$$x0
001025208 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
001025208 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x2
001025208 980__ $$aabstract
001025208 980__ $$aVDB
001025208 980__ $$aI:(DE-Juel1)INM-1-20090406
001025208 980__ $$aI:(DE-Juel1)INM-4-20090406
001025208 980__ $$aI:(DE-Juel1)INM-3-20090406
001025208 980__ $$aUNRESTRICTED